These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28611375)

  • 1. Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening.
    Mouhsine H; Guillemain H; Moreau G; Fourati N; Zerrouki C; Baron B; Desallais L; Gizzi P; Ben Nasr N; Perrier J; Ratsimandresy R; Spadoni JL; Do H; England P; Montes M; Zagury JF
    Sci Rep; 2017 Jun; 7(1):3424. PubMed ID: 28611375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of highly potent TNFα inhibitors using virtual screen.
    Shen Q; Chen J; Wang Q; Deng X; Liu Y; Lai L
    Eur J Med Chem; 2014 Oct; 85():119-26. PubMed ID: 25078315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small-molecule tumor necrosis factor α inhibitor attenuates inflammation in a hepatitis mouse model.
    Ma L; Gong H; Zhu H; Ji Q; Su P; Liu P; Cao S; Yao J; Jiang L; Han M; Ma X; Xiong D; Luo HR; Wang F; Zhou J; Xu Y
    J Biol Chem; 2014 May; 289(18):12457-66. PubMed ID: 24634219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel inhibitors for TNFα, TNFR1 and TNFα-TNFR1 complex using pharmacophore-based approaches.
    Saddala MS; Huang H
    J Transl Med; 2019 Jul; 17(1):215. PubMed ID: 31266509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Innovative High-Throughput Screening Approach for Discovery of Small Molecules That Inhibit TNF Receptors.
    Lo CH; Vunnam N; Lewis AK; Chiu TL; Brummel BE; Schaaf TM; Grant BD; Bawaskar P; Thomas DD; Sachs JN
    SLAS Discov; 2017 Sep; 22(8):950-961. PubMed ID: 28530838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of an anti-inflammatory peptide from Hydrophis cyanocinctus and analysis of its activities and mechanism in DSS-induced acute colitis.
    Zheng Z; Jiang H; Huang Y; Wang J; Qiu L; Hu Z; Ma X; Lu Y
    Sci Rep; 2016 May; 6():25672. PubMed ID: 27158082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chebulagic acid Chebulinic acid and Gallic acid, the active principles of Triphala, inhibit TNFα induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation.
    Shanmuganathan S; Angayarkanni N
    Vascul Pharmacol; 2018 Sep; 108():23-35. PubMed ID: 29678603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
    Mourey RJ; Burnette BL; Brustkern SJ; Daniels JS; Hirsch JL; Hood WF; Meyers MJ; Mnich SJ; Pierce BS; Saabye MJ; Schindler JF; South SA; Webb EG; Zhang J; Anderson DR
    J Pharmacol Exp Ther; 2010 Jun; 333(3):797-807. PubMed ID: 20237073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modifying TNFalpha for therapeutic use: a perspective on the TNF receptor system.
    Hasegawa A; Takasaki W; Greene MI; Murali R
    Mini Rev Med Chem; 2001 May; 1(1):5-16. PubMed ID: 12369987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sesquiterpene lactone from a medicinal herb inhibits proinflammatory activity of TNF-α by inhibiting ubiquitin-conjugating enzyme UbcH5.
    Liu L; Hua Y; Wang D; Shan L; Zhang Y; Zhu J; Jin H; Li H; Hu Z; Zhang W
    Chem Biol; 2014 Oct; 21(10):1341-1350. PubMed ID: 25200604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production on macrophages and microglia by a standard aqueous extract of Mangifera indica L. (VIMANG). Role of mangiferin isolated from the extract.
    Garrido G; Delgado R; Lemus Y; Rodríguez J; García D; Núñez-Sellés AJ
    Pharmacol Res; 2004 Aug; 50(2):165-72. PubMed ID: 15177305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energy-Based Pharmacophore and Three-Dimensional Quantitative Structure--Activity Relationship (3D-QSAR) Modeling Combined with Virtual Screening To Identify Novel Small-Molecule Inhibitors of Silent Mating-Type Information Regulation 2 Homologue 1 (SIRT1).
    Pulla VK; Sriram DS; Viswanadha S; Sriram D; Yogeeswari P
    J Chem Inf Model; 2016 Jan; 56(1):173-87. PubMed ID: 26636371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of binding proteins for a protein target using protein-protein docking-based virtual screening.
    Zhang C; Tang B; Wang Q; Lai L
    Proteins; 2014 Oct; 82(10):2472-82. PubMed ID: 24854898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130.
    Hong SS; Choi JH; Lee SY; Park YH; Park KY; Lee JY; Kim J; Gajulapati V; Goo JI; Singh S; Lee K; Kim YK; Im SH; Ahn SH; Rose-John S; Heo TH; Choi Y
    J Immunol; 2015 Jul; 195(1):237-45. PubMed ID: 26026064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based discovery of a small non-peptidic Neuropilins antagonist exerting in vitro and in vivo anti-tumor activity on breast cancer model.
    Borriello L; Montès M; Lepelletier Y; Leforban B; Liu WQ; Demange L; Delhomme B; Pavoni S; Jarray R; Boucher JL; Dufour S; Hermine O; Garbay C; Hadj-Slimane R; Raynaud F
    Cancer Lett; 2014 Jul; 349(2):120-7. PubMed ID: 24752068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.
    Yang F; de Villiers WJ; McClain CJ; Varilek GW
    J Nutr; 1998 Dec; 128(12):2334-40. PubMed ID: 9868178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug Design.
    Dietrich JD; Longenecker KL; Wilson NS; Goess C; Panchal SC; Swann SL; Petros AM; Hobson AD; Ihle D; Song D; Richardson P; Comess KM; Cox PB; Dombrowski A; Sarris K; Donnelly-Roberts DL; Duignan DB; Gomtsyan A; Jung P; Krueger AC; Mathieu S; McClure A; Stoll VS; Wetter J; Mankovich JA; Hajduk PJ; Vasudevan A; Stoffel RH; Sun C
    J Med Chem; 2021 Jan; 64(1):417-429. PubMed ID: 33378180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice.
    Park D; Park CW; Choi Y; Lin J; Seo DH; Kim HS; Lee SY; Kang IC
    Biomaterials; 2016 Aug; 98():131-42. PubMed ID: 27187277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents.
    Nesbitt A; Fossati G; Bergin M; Stephens P; Stephens S; Foulkes R; Brown D; Robinson M; Bourne T
    Inflamm Bowel Dis; 2007 Nov; 13(11):1323-32. PubMed ID: 17636564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory 'double hit' model of temporomandibular joint disorder with elevated CCL2, CXCL9, CXCL10, RANTES and behavioural hypersensitivity in TNFR1/R2-/- mice.
    McIlwrath SL; Nesemeier R; Ma F; Oz HS; Zhang L; Westlund KN
    Eur J Pain; 2017 Aug; 21(7):1209-1223. PubMed ID: 28318085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.